Evidence map›Paper›PMID 26093152›Full record

ArticleJournal of molecular and cellular cardiology2016

Reduced response to IKr blockade and altered hERG1a/1b stoichiometry in human heart failure.

Katherine M Holzem, Juan F Gomez, Alexey V Glukhov, Eli J Madden, Aaron C Koppel, Gregory A Ewald, Beatriz Trenor, Igor R Efimov

Open access · bronzeAbstract read
In one paragraph

Article in Journal of molecular and cellular cardiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  8. Article
  9. Acetylcholine Reduces IBiomedicines · 2022
    Article
  10. Article
  11. Long QT SyndromeCirculation. Arrhythmia and electrophysiology · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Katherine M HolzemDepartment of Biomedical Engineering, Washington University in St. Louis, MO 63130, USA.
Juan F GomezPolytechnic University of Valencia, Valencia, Spain.
Alexey V GlukhovDepartment of Biomedical Engineering, Washington University in St. Louis, MO 63130, USA.
Eli J MaddenDepartment of Biomedical Engineering, Washington University in St. Louis, MO 63130, USA.
Aaron C KoppelDepartment of Biomedical Engineering, Washington University in St. Louis, MO 63130, USA.
Gregory A EwaldDepartment of Biomedical Engineering, Washington University in St. Louis, MO 63130, USA.
Beatriz TrenorPolytechnic University of Valencia, Valencia, Spain.
Igor R EfimovDepartment of Biomedical Engineering, Washington University in St. Louis, MO 63130, USA; Moscow Institute of Physics and Technology, Dolgoprudny, Moscow Region, Russia. Electronic address: igor@wustl.edu.
Washington University in St. Louis · USUniversitat Politècnica de València · ESMoscow Institute of Physics and Technology · RU

Funding

Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
ARRHYTHMOGENIC REMODELING IN HUMAN HEART FAILURER01HL114395 · NHLBI · WASHINGTON UNIVERSITY · PI EFIMOV, IGOR R · 2012 to 2015
$2.1M
Arrhythmogenic Remodeling of Repolarization in Human Heart FailureF30HL114310 · NHLBI · WASHINGTON UNIVERSITY · PI HOLZEM, KATHERINE MARIE · 2013 to 2016
$174k
NCATS NIH HHS UL1 TR000448NHLBI NIH HHS F30 HL114310NHLBI NIH HHS R01 HL114395
6 · The paper itself

Abstract

Heart failure (HF) claims 250,000 lives per year in the US, and nearly half of these deaths are sudden and presumably due to ventricular tachyarrhythmias. QT interval and action potential (AP) prolongation are hallmark proarrhythmic changes in the failing myocardium, which potentially result from alterations in repolarizing potassium currents. Thus, we aimed to examine whether decreased expression of the rapid delayed rectifier potassium current, IKr, contributes to repolarization abnormalities in human HF. To map functional IKr expression across the left ventricle (LV), we optically imaged coronary-perfused LV free wall from donor and end-stage failing human hearts. The LV wedge preparation was used to examine transmural AP durations at 80% repolarization (APD80), and treatment with the IKr-blocking drug, E-4031, was utilized to interrogate functional expression. We assessed the percent change in APD80 post-IKr blockade relative to baseline APD80 (∆APD80) and found that ∆APD80s are reduced in failing versus donor hearts in each transmural region, with 0.35-, 0.43-, and 0.41-fold reductions in endo-, mid-, and epicardium, respectively (p=0.008, 0.037, and 0.022). We then assessed hERG1 isoform gene and protein expression levels using qPCR and Western blot. While we did not observe differences in hERG1a or hERG1b gene expression between donor and failing hearts, we found a shift in the hERG1a:hERG1b isoform stoichiometry at the protein level. Computer simulations were then conducted to assess IKr block under E-4031 influence in failing and nonfailing conditions. Our results confirmed the experimental observations and E-4031-induced relative APD80 prolongation was greater in normal conditions than in failing conditions, provided that the cellular model of HF included a significant downregulation of IKr. In human HF, the response to IKr blockade is reduced, suggesting decreased functional IKr expression. This attenuated functional response is associated with altered hERG1a:hERG1b protein stoichiometry in the failing human LV, and failing cardiomyoctye simulations support the experimental findings. Thus, of IKr protein and functional expression may be important determinants of repolarization remodeling in the failing human LV.

Indexed as

Action PotentialsAdolescentAdultAnti-Arrhythmia AgentsComputer SimulationERG1 Potassium ChannelFemaleGene ExpressionHeart FailureHeart VentriclesHumansMaleMiddle AgedModels, BiologicalMyocardiumPiperidinesAnti-Arrhythmia AgentsE 4031ERG1 Potassium ChannelKCNH2 protein, humanPiperidinesPotassiumPyridinesArrhythmiasHeart failurePotassium channelsRemodelingRepolarization

Identifiers

PMID26093152
PMCPMC4683114
OpenAlexW1512840122

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.